NOVAICOS ImmunoTherapeutics is a new biotech company focused on innovative approach for the therapy of bone-loss related diseases. Novaicos develops its patented active substance, the only immune-derived compound at the state-of-the-art with a relevant role in inhibiting bone erosion even in osteoporosis and in bone metastasis, with potential properties as modularity, reversibility and tolerability.
| Website | http://www.novaicos.com |
| Revenue | $3 million |
| Employees | 3 (2 on RocketReach) |
| Founded | 2016 |
| Phone | +39 0321 660658 |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Immunotherapy, Biotechnology, Novel Therapeutics, Osteoporosis Treatment, Bone Health, Pharmaceutical Research, Drug Development, Clinical Trials, Biotech, Regenerative Medicine, Bone Metabolism, Skeletal Health, Aging, Rare Bone Disease, Innovative Therapies |
| Competitors | ServiceTitan, Splunk, Dynatrace, Datadog, GitLab, Elastic, PagerDuty, Sumo Logic, Sysdig, Tremolo Security Inc. +52 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Novaicos employee's phone or email?
Novaicos Questions
The Novaicos annual revenue was $3 million in 2026.
Giovanni Cerutti is the CEO and Managing Director of Novaicos.
2 people are employed at Novaicos.
The NAICS codes for Novaicos are [3254, 325, 32].
The SIC codes for Novaicos are [283, 28, 80].
Top Novaicos Employees
Related Companies
